SCHEMBL15567474

SCHEMBL15567474

COC(=O)c1ccc(-c2cc3ccc(F)cc3c(=O)[nH]2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.57
TNKS O95271 3/20 0.52
MAP2K4 P45985 1/20 0.50
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
MAPK13 O15264 1/20 0.43
ALOX5 P09917 1/20 0.43
GCGR P47871 1/20 0.43
MAPK12 P53778 1/20 0.43
MAPK11 Q15759 1/20 0.43
MAPK14 Q16539 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
GSK3B P49841 1/20 0.43
BRD4 O60885 1/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MAPK1 P28482 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16931442 0.84 TNKS (0.53) PARP1TNKSMAP2K4ALDH1A1KDM4E
SCHEMBL15568043 0.83 TNKS (0.60) PARP1TNKSALDH1A1KDM4EHPGD
SCHEMBL15569068 0.82 TNKS (0.54) PARP1TNKSMEN1KMT2AALDH1A1
SCHEMBL15567513 0.80 SMN1; SMN2 (0.61) PARP1TNKSMEN1KMT2AALDH1A1
SCHEMBL16965338 0.78 TNKS (0.70) PARP1TNKSMAP2K4ALDH1A1KDM4E
SCHEMBL15568268 0.77 TNKS (0.56) PARP1TNKSMEN1KMT2AALDH1A1
SCHEMBL15568327 0.77 TNKS (0.62) PARP1TNKS
SCHEMBL30469362 0.76 ULK1 (0.65)
SCHEMBL167256 0.75 HDAC6 (0.52) PARP1MAP2K4MEN1KMT2AKDM4E
SCHEMBL29893090 0.75 PARP1 (0.46) PARP1TNKSALDH1A1KDM4EMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2882714-A2 (AZA-)ISOQUINOLINONE DERIVATIVES Merck Patent GmbH (DE) 2015-06-17 EP claimed
WO-2014023390-A2 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2014-02-13 WO claimed
EP-2882714-B1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-11-13 EP disclosed
US-9376433-B2 (AZA-)isoquinolinone derivatives MERCK PATENT GMBH (DE) 2016-06-28 US disclosed
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2015-07-30 US disclosed
EP-2882714-A2 (AZA-)ISOQUINOLINONE DERIVATIVES Merck Patent GmbH (DE) 2015-06-17 EP disclosed
WO-2014023390-A2 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2014-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES TANK, TNKS, TDP1 PARP1 39/4885TNKS 2/4885MAP2K4 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.